| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mads Gyrd-Hansen, Thomas O B Krag, Alan G Rosmarin, Tejvir S Khuran. Sp1 and the ets-related transcription factor complex GABP alpha/beta functionally cooperate to activate the utrophin promoter. Journal of the neurological sciences. vol 197. issue 1-2. 2002-07-03. PMID:11997063. |
duchenne muscular dystrophy (dmd) is a fatal neuromuscular disease caused by the absence of dystrophin. |
2002-07-03 |
2023-08-12 |
drosophila_melanogaster |
| K Gieseler, K Grisoni, L Ségala. Genetic suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans. Current biology : CB. vol 10. issue 18. 2000-12-07. PMID:10996789. |
dystrophin is the product of the gene that is mutated in duchenne muscular dystrophy (dmd), a progressive neuromuscular disease for which no treatment is available. |
2000-12-07 |
2023-08-12 |
mouse |
| A H Ligon, C D Kashork, C S Richards, L G Shaffe. Identification of female carriers for Duchenne and Becker muscular dystrophies using a FISH-based approach. European journal of human genetics : EJHG. vol 8. issue 4. 2000-09-01. PMID:10854113. |
duchenne muscular dystrophy (dmd) and becker muscular dystrophy (bmd) are x-linked recessive neuromuscular diseases caused by dystrophin gene mutations. |
2000-09-01 |
2023-08-12 |
Not clear |
| M A Alcántara, M T Villarreal, V Del Castillo, G Gutiérrez, Y Saldaña, I Maulen, R Lee, M Macías, L Orozc. High frequency of de novo deletions in Mexican Duchenne and Becker muscular dystrophy patients. Implications for genetic counseling. Clinical genetics. vol 55. issue 5. 1999-08-24. PMID:10422811. |
duchenne muscular dystrophy (dmd) is the most common lethal hereditary neuromuscular disease. |
1999-08-24 |
2023-08-12 |
Not clear |
| Y Saito, T Komiya, M Kawa. [Hypercoagulable state in Duchenne muscular dystrophy]. Rinsho shinkeigaku = Clinical neurology. vol 37. issue 5. 1997-12-16. PMID:9294322. |
significantly smaller number of the control patients suffering from other neuromuscular diseases showed abnormal results, while the ambulatory dmd patients not infrequently showed hypercoagulable state. |
1997-12-16 |
2023-08-12 |
Not clear |
| A Marbini, F Gemignani, M F Bellanova, D Guidetti, A Ferrar. Immunohistochemical localization of utrophin and other cytoskeletal proteins in skin smooth muscle in neuromuscular diseases. Journal of the neurological sciences. vol 143. issue 1-2. 1997-03-20. PMID:8981315. |
we investigated the immunohistochemical distribution of cytoskeletal proteins in smooth muscles of 15 patients with duchenne muscular dystrophy (dmd), 8 patients with becker muscular dystrophy (bmd), 28 patients with various neuromuscular diseases, and 2 normal controls, performing skin and muscle biopsies. |
1997-03-20 |
2023-08-12 |
Not clear |
| A Marbini, F Gemignani, M F Bellanova, D Guidetti, A Ferrar. Immunohistochemical localization of utrophin and other cytoskeletal proteins in skin smooth muscle in neuromuscular diseases. Journal of the neurological sciences. vol 143. issue 1-2. 1997-03-20. PMID:8981315. |
dystrophin immunostaining confirmed absent reaction in the arrector pili muscles of dmd patients, faint positive reaction in bmd patients, and strong dystrophin reaction in patients with other neuromuscular diseases and normal controls. |
1997-03-20 |
2023-08-12 |
Not clear |
| A Marbini, F Gemignani, M F Bellanova, D Guidetti, A Ferrar. Immunohistochemical localization of utrophin and other cytoskeletal proteins in skin smooth muscle in neuromuscular diseases. Journal of the neurological sciences. vol 143. issue 1-2. 1997-03-20. PMID:8981315. |
staining of the capillary endothelial cells and muscular vessel walls was seen in normal controls, as well as in dmd, bmd, and other neuromuscular diseases. |
1997-03-20 |
2023-08-12 |
Not clear |
| I Nonak. [Muscle pathologic diagnosis--mechanism in muscle fiber degeneration]. Rinsho shinkeigaku = Clinical neurology. vol 34. issue 12. 1995-07-11. PMID:7774135. |
in various neuromuscular diseases, the most significant muscle degeneration is muscle fiber necrosis as seen in duchenne muscular dystrophy (dmd). |
1995-07-11 |
2023-08-12 |
mouse |
| A Oldfors, T Martinsson, I Tessin, J Wahlström, S Wan. Duchenne muscular dystrophy and spinal muscular atrophy type I segregating in the same family. Clinical genetics. vol 45. issue 2. 1994-07-19. PMID:8004806. |
we report on a family with two severe neuromuscular diseases: duchenne muscular dystrophy (dmd) and acute infantile spinal muscular atrophy (sma i). |
1994-07-19 |
2023-08-12 |
Not clear |
| R Mongiorgi, A C Ballestrazzi, C Granata, G Bertocchi, G Maggi, S Gnudi, M G Gandolf. Morphological and structural characteristics of the myopathic bone. Bollettino della Societa italiana di biologia sperimentale. vol 69. issue 5. 1994-04-15. PMID:8129910. |
to this end, samples from 8 patients affected by different neuromuscular diseases (dmd, sma and cmd) have been examined. |
1994-04-15 |
2023-08-12 |
Not clear |
| J E Anderson, D L Lentz, R B Johnso. Recovery from disuse osteopenia coincident to restoration of muscle strength in mdx mice. Bone. vol 14. issue 4. 1994-02-08. PMID:8274305. |
these observations suggest that data are needed regarding bone mass and muscle-bone attachments in humans with disuse osteopenia, dmd, and other neuromuscular diseases. |
1994-02-08 |
2023-08-12 |
mouse |
| Y K Hayashi, E Engvall, E Arikawa-Hirasawa, K Goto, R Koga, I Nonaka, H Sugita, K Arahat. Abnormal localization of laminin subunits in muscular dystrophies. Journal of the neurological sciences. vol 119. issue 1. 1994-01-05. PMID:8246011. |
to address potential involvement of muscle basal lamina and membrane cytoskeleton proteins in the etiology of non-dystrophinopathy muscular dystrophies, we examined the immunostaining intensity and distribution of laminin subunits (a, b1, b2 and m), type iv collagen, dystrophin and spectrin in skeletal muscle biopsies from 64 myopathic patients (17 fukuyama congenital muscular dystrophy: fcmd, 13 congenital muscular dystrophy unrelated to fcmd: other cmd, 16 duchenne muscular dystrophy: dmd, and 18 other neuromuscular diseases. |
1994-01-05 |
2023-08-12 |
Not clear |
| A S Oliveira, A A Gabbai, B Schmidt, B H Kiyomoto, J G Lima, C Minetti, E Bonill. Carrier detection of Duchenne and Becker muscular dystrophy using muscle dystrophin immunohistochemistry. Arquivos de neuro-psiquiatria. vol 50. issue 4. 1993-10-21. PMID:1309152. |
this method is also helpful to distinguish manifesting dmd carriers from patients with other neuromuscular diseases like limb-girdle muscular dystrophy and spinal muscular atrophy. |
1993-10-21 |
2023-08-11 |
Not clear |
| D G Cziner, R I Levi. The cardiomyopathy of Duchenne's muscular dystrophy and the function of dystrophin. Medical hypotheses. vol 40. issue 3. 1993-07-01. PMID:8502196. |
duchenne's muscular dystrophy (dmd) is a common x-linked neuromuscular disease which predominantly affects skeletal and cardiac muscle. |
1993-07-01 |
2023-08-12 |
Not clear |
| K Ohlendieck, K Matsumura, V V Ionasescu, J A Towbin, E P Bosch, S L Weinstein, S W Sernett, K P Campbel. Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology. vol 43. issue 4. 1993-05-11. PMID:8469343. |
the results revealed a dramatic reduction in all of the dystrophin-associated proteins in the sarcolemma of dmd muscle compared with normal muscle and muscle from a variety of other neuromuscular diseases. |
1993-05-11 |
2023-08-12 |
Not clear |
| O Yahara, K Hashimoto, N Taniguchi, M Ishikawa, Y Sato, H Yamashita, H Ohn. Serum manganese-superoxide dismutase in patients with neuromuscular disorders as judged by an ELISA. Research communications in chemical pathology and pharmacology. vol 72. issue 3. 1991-12-13. PMID:1947435. |
manganese-superoxide dismutase (mn-sod) concentration was measured in sera from 37 healthy controls and 101 patients with 11 forms of neuromuscular diseases including duchenne muscular dystrophy (dmd) and polymyositis (pms) by an enzyme-linked immunosorbent assay with the use of a monoclonal antibody against human liver mn-sod. |
1991-12-13 |
2023-08-11 |
human |
| K Matsumura, T Toda, T Hasegawa, M Kamei, N Imoto, T Shimiz. A Japanese family with two types of muscular dystrophy: DNA analysis and the dystrophin test. Journal of child neurology. vol 6. issue 3. 1991-09-26. PMID:1875028. |
four boys, all from the sixth generation of the same family, were afflicted with severe neuromuscular diseases beginning in early life, three of them presenting the typical phenotype of fcmd and one, that of dmd. |
1991-09-26 |
2023-08-11 |
Not clear |
| T M Ko, C F Chen, H C Chiu, F J Hsieh, T Y Le. Molecular analysis of 25 Chinese families with Duchenne/Becker muscular dystrophy. Journal of the Formosan Medical Association = Taiwan yi zhi. vol 89. issue 10. 1991-04-23. PMID:1981771. |
duchenne muscular dystrophy (dmd) and becker muscular dystrophy (bmd) are allelic x-linked progressive neuromuscular diseases. |
1991-04-23 |
2023-08-11 |
human |
| C Webster, H M Bla. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy. Somatic cell and molecular genetics. vol 16. issue 6. 1991-02-12. PMID:2267630. |
we compared the life-span of myoblasts from eight dmd patients with controls: three individuals with no known neuromuscular disease, three dmd carriers, and three patients with other muscle degenerative diseases. |
1991-02-12 |
2023-08-11 |
Not clear |